Assignee
CURIS INC
US·107 granted patents·41 pending applications·2,268 citations·filing 1994–2025
Top patents by PatentIndex Score
148 records- 0198US6613798B1Small organic molecule regulators of cell proliferationCURIS INC·Filed 2000·Granted Sep 2, 2003·213 cites·59 claims
- 0297US7115653B2Small organic molecule regulators of cell proliferationCURIS INC·Filed 2002·Granted Oct 3, 2006·130 cites·29 claims
- 0397US6552016B1Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2000·Granted Apr 22, 2003·92 cites·43 claims
- 0496US6683108B1Agonists of hedgehog signaling pathways and uses related theretoCURIS INC·Filed 2000·Granted Jan 27, 2004·61 cites·75 claims
- 0596US6545005B1Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2000·Granted Apr 8, 2003·188 cites·35 claims
- 0695US11040948B2Crystal forms of immunomodulatorsCURIS INC·Filed 2018·Granted Jun 22, 2021·12 cites·25 claims
- 0795US8906909B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2013·Granted Dec 9, 2014·17 cites·20 claims
- 0895US7547781B2Quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Jun 16, 2009·15 cites·9 claims
- 0995US6683192B2Small organic molecule regulators of cell proliferationCURIS INC·Filed 2001·Granted Jan 27, 2004·113 cites·30 claims
- 1093US11643401B2Crystal forms of immunomodulatorsCURIS INC·Filed 2021·Granted May 9, 2023·4 cites·12 claims
- 1193US10758518B2Compounds and compositions for treating hematological disordersCURIS INC·Filed 2018·Granted Sep 1, 2020·8 cites·7 claims
- 1293US10676482B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2019·Granted Jun 9, 2020·3 cites·4 claims
- 1393US7300929B2Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2003·Granted Nov 27, 2007·30 cites·40 claims
- 1492US11939306B2Crystal forms of immunomodulatorsCURIS INC·Filed 2023·Granted Mar 26, 2024·2 cites·12 claims
- 1592US8367663B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2010·Granted Feb 5, 2013·17 cites·25 claims
- 1692US6326201B1Pancreatic progenitor cells, methods and uses related theretoCURIS INC·Filed 2000·Granted Dec 4, 2001·186 cites·39 claims
- 1792US6291516B1Regulators of the hedgehog pathway, compositions and uses related theretoCURIS INC·Filed 1999·Granted Sep 18, 2001·105 cites·16 claims
- 1891US10336770B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2017·Granted Jul 2, 2019·7 cites·13 claims
- 1991US8357368B2Methods of treating pancreatic or liver cancer using hedgehog antagonistsCURIS INC·Filed 2010·Granted Jan 22, 2013·24 cites·24 claims
- 2091US6686388B2Regulators of the hedgehog pathway, compositions and uses related theretoCURIS INC·Filed 2001·Granted Feb 3, 2004·48 cites·14 claims
- 2191US2025230169A1Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding MoietyCURIS INC·Filed 2024·Application pending·0 cites
- 2290US9725461B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2014·Granted Aug 8, 2017·11 cites·18 claims
- 2390US6861404B1Therapies for chronic renal failureCURIS INC·Filed 1997·Granted Mar 1, 2005·82 cites·32 claims
- 2489US7888364B2Pyridyl inhibitors of hedgehog signallingCURIS INC·Filed 2005·Granted Feb 15, 2011·10 cites·55 claims
- 2589US7396809B1Methods and reagents for treating glucose metabolic disordersCURIS INC·Filed 2000·Granted Jul 8, 2008·45 cites·65 claims
- 2688US9657032B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2015·Granted May 23, 2017·5 cites·21 claims
- 2788US9249156B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2014·Granted Feb 2, 2016·6 cites·9 claims
- 2888US7977347B2Quinazoline based EGFR inhibitorsCURIS INC·Filed 2007·Granted Jul 12, 2011·11 cites·10 claims
- 2988US7807641B2Methods and reagents for treating glucose metabolic disordersCURIS INC·Filed 2007·Granted Oct 5, 2010·12 cites·34 claims
- 3088US7498304B2Angiogenesis-modulating compositions and usesCURIS INC·Filed 2003·Granted Mar 3, 2009·30 cites·69 claims
- 3188US7445778B2Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses thereforCURIS INC·Filed 2001·Granted Nov 4, 2008·16 cites·52 claims
- 3288US6639051B2Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related theretoCURIS INC·Filed 1998·Granted Oct 28, 2003·51 cites·28 claims
- 3388US6498142B1Morphogen treatment for chronic renal failureCURIS INC·Filed 1996·Granted Dec 24, 2002·56 cites·24 claims
- 3487US6616926B1Methods of modulating lipid metabolism and storageCURIS INC·Filed 2000·Granted Sep 9, 2003·21 cites·8 claims
- 3586US6506729B1Methods and compositions for the treatment and prevention of Parkinson's diseaseCURIS INC·Filed 1997·Granted Jan 14, 2003·32 cites·6 claims
- 3686US6495513B1Morphogen-enhanced survival and repair of neural cellsCURIS INC·Filed 1995·Granted Dec 17, 2002·31 cites·2 claims
- 3786US2023192687A1Fused amino pyridine as hsp90 inhibitorsCURIS INC·Filed 2022·Application pending·0 cites
- 3885US6407060B1Method for enhancing functional recovery following central nervous system ischemia or traumaCURIS INC·Filed 1997·Granted Jun 18, 2002·52 cites·30 claims
- 3985US2023227467A1Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2023·Application pending·0 cites
- 4084US7816369B2Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2005·Granted Oct 19, 2010·7 cites·13 claims
- 4184US7708998B2Methods of inhibiting unwanted cell proliferation using hedgehog antagonistsCURIS INC·Filed 2003·Granted May 4, 2010·11 cites·63 claims
- 4284US6207804B1Genetically engineered antibody analogues and fusion proteins thereofCURIS INC·Filed 1995·Granted Mar 27, 2001·41 cites·6 claims
- 4383US12178821B2Combination therapies for the treatment of cancerCURIS INC·Filed 2022·Granted Dec 31, 2024·2 cites·30 claims
- 4483US11597732B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2022·Granted Mar 7, 2023·0 cites·6 claims
- 4583US8846912B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Sep 30, 2014·2 cites·17 claims
- 4683US7846938B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2008·Granted Dec 7, 2010·4 cites·25 claims
- 4783US7056882B2Treatment to prevent loss of and/or increase bone mass in metabolic bone diseasesCURIS INC·Filed 2001·Granted Jun 6, 2006·9 cites·40 claims
- 4882US12252475B2Crystal forms of immunomodulatorsCURIS INC·Filed 2024·Granted Mar 18, 2025·0 cites·8 claims
- 4982US9169244B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Oct 27, 2015·4 cites·10 claims
- 5082US7888361B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Feb 15, 2011·4 cites·9 claims
Showing the top 50 of 148 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CURIS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →